Meghmani Finechem into chlorotoluene
Indian chlor-alkali producer Meghmani Finechem is to spend €21.6 million to expand into the chlorotoluene value chain at its site in Dahej, Gujarat. Due to be commissioned by Q4 2024, this will be the first plant in India to be back-integrated into toluene chlorination, and will produce pharmaceutical and agrochemical intermediates.
The company is simultaneously investing in an R&D centre for chlorotoluene at Changodar, near Ahmedabad, “which will help the company identify new molecules in Chlorotoluene eco-system and further strengthen the fully integrated facility This investment in R&D centre will be the foundation for the next phase of growth of speciality chemical market,” the company said.
RELATED ARTICLES
AlzChem plans to “significantly increase” its nitroguanidine capacity, with a new production plant that will almost double the €76 million expansion it announced in the spring.
Karsten Smet, CEO of ACI Group, looks at ways the pharmaceutical and agrochemical industries can adapt to changing times
BASF is to end production of three chemicals at its main site in Ludwigshafen. This is part of an ongoing strategic review that is being undertaken “to ensure competitiveness under changing market conditions” and will lead to about 180 job cuts.
Barentz International has acquired distributors in two different regions in short order. The acquisition of Insuqui in Paraguay followed a few weeks after that of the Anshul Life Sciences Group in India.
Price pressure stalls re-shoring in US agrochemicals, but business was brisk with positive energy at the Specialty & Agro Chemicals America event. Gregory D.L. Morris reports from Savannah
FMC Corporation has agreed to sell its Global Specialty Solutions (GSS) business to Envu for $350 million, subject to closing working capital adjustment. The deal is expected to close by year-end 2024, subject to regulatory approval and other customary closing conditions.
